ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Jardiance commercial milestone collaboration revenue by Quarter
Jardiance commercial milestone collaboration revenue ($M) ($M)
Eli Lilly Jardiance commercial milestone collaboration revenue: $250M in Q2 2026.
Latest, Q2 2026
250
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
6 quarters
Since Q1 2025
Sources
4
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Note 2.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Jardiance commercial milestone collaboration revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 250 | – | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 250 | -32.4% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 0 | – | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 200 | – | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 0 | – | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 370 | – | Form 10-Q (filed 2026-04-30) ↗ |
Cite this data
StockData. (2026). Eli Lilly Jardiance commercial milestone collaboration revenue ($M), quarterly Q1 2025–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-jardiance-milestone
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.